BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31611208)

  • 1. The Value of Combination Analysis of Tumor Biomarkers for Early Differentiating Diagnosis of Lung Cancer and Pulmonary Tuberculosis.
    Jia H; Zhang L; Wang B
    Ann Clin Lab Sci; 2019 Sep; 49(5):645-649. PubMed ID: 31611208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y; Wang Z; Ding Y; Sun F; Ding X
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
    Ni LF; Liu XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J; Guo Z; Zhang L
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
    BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
    Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
    Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
    Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.
    Dou X; Lu J; Yu Y; Yi Y; Zhou L
    Dis Markers; 2024; 2024():4782618. PubMed ID: 38549716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
    Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
    Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer.
    Li J; Chen Y; Wang X; Wang C; Xiao M
    Transl Cancer Res; 2021 Apr; 10(4):1900-1906. PubMed ID: 35116511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):641-647. PubMed ID: 27760591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ; Tao Z; Gu W; Sun LH
    Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
    Wang P; Piao Y; Zhang X; Li W; Hao X
    Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
    Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
    Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
    Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utilization pattern of serum tumor markers in lung cancer patients: A population-based retrospective descriptive study.
    Wang H; Zhang J; Li X; Zhang C; Zheng S; Chi Y; Sheng X; Zhang Y
    J Clin Lab Anal; 2020 Nov; 34(11):e23465. PubMed ID: 32638440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the best prognostic value of serum tumor markers in patients with suspected lung cancer in an Iranian population.
    Sigari N; Mohsenpour B; Nikkhoo B; Ghaderi B; Afkhamzadeh A; Azadi NA; Fathi F; Abdi M
    Clin Lab; 2014; 60(1):23-7. PubMed ID: 24600971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.